Back to Selection     Print       Date : 30 Jun 2026
Fund Summary
SBI Large & Midcap Fund Reg (G)
[Equity: Large & Mid Cap]  
 
Fund Details
Fund Type Growth Launch Date 28-Feb-93
Corpus(Cr.) 40850.0 Latest NAV 656.2977 As on 29-07-2026
Equity(%) 96.24 52 Week High 662.381
Debt(%) 3.21 52 Week Low 578.837
Others(%) 0.0 Exit Load 0.1% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.29
Scheme Benchmark NIFTY Large Midcap 250 TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Saurabh Pant
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to provide the investor with the opportunity of long-term capital appreciation by investing in diversified portfolio comprising predominantly large cap and mid cap companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 20.45%
Top 10 Holdings 32.40%
Top 25 Holdings 61.60%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Banking & Financial 19.42
Pharma & Biotech 12.69
Automobile 8.07
Consumer Durables 7.6
Construction 5.02
FMCG 4.87
Energy 4.51
Software & Services 4.46
Agricultural & Farm Machinery 4.37
Industrial Products 3.07
Petroleum Products 2.83
Retail 2.66
Cash 2.52
Ferrous Metals 2.49
Trading 2.29
Food Beverage & Tobacco 2.03
Miscellaneous 1.93
Transportation 1.69
Textiles 1.42
Telecom 1.35
SERVICES 1.24
SOV 0.69
Finance & Investments 0.58
Global Equity 0.55
Healthcare 0.52
Chemicals 0.46
Metals 0.44
Oil & GAS 0.23
 
 
 
 
 
Portfolio Metrics
PB Ratio 0.00
PE Ratio 27.33
 
Top 25 Holdings
Holdings Net Asset(%)
HDFC Bank Limited 7.42
Axis Bank Limited 3.62
ICICI Bank Limited 3.50
TREPS 3.02
State Bank of India 2.89
Berger Paints (I) Limited 2.50
ASIAN PAINTS (INDIA) LTD. 2.48
Bharat Forge Limited 2.47
Adani Enterprises 2.29
Tata Motors Limited 2.21
Balkrishna Industries Limited 2.17
Ashok Leyland Ltd 2.16
Shree Cement Limited 2.07
Aurobindo Pharma Limited 2.07
Biocon Limited 2.05
Reliance Industries Limited 2.03
Colgate - Palmolive (India) Ltd. 2.03
Alkem Laboratories Limited 2.01
Gland Pharma Limited 1.94
HDFC Life Insurance Co Ltd 1.93
Abbott India Limited 1.92
Jindal Steel & Power Limited 1.85
Torrent Power Limited 1.75
ICICI Prudential AMC Ltd 1.63
United Breweries Limited 1.59

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
1.96% 4.31% 2.38% 5.37%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.46% 0.94% -3.91% -1.20%
 
Scheme Benchmark [NSE - Nifty Large Midcap 250 TRI]
1.79% 2.88% 2.92% 4.38%
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
4.39% 13.75% 14.17% 14.38%
 
 
0.01% 8.55% 10.25% 12.21%
 
 
2.05% 14.59% 14.50% 15.19%
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
SBI Large & Midcap Fund Reg (G) 13.47% 0.5389 11.1745% 42.8954 0.0917
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
SBI Large & Midcap Fund Reg (G) 5.7346% 0.0004 0.0923 6.4269 1.1707
 
Back to Selection